Is universal tumor testing for Lynch syndrome cost-effective? It depends!
Genet Med
.
2019 Jan;21(1):252-253.
doi: 10.1038/s41436-018-0025-5.
Epub 2018 May 15.
Author
Scott D Grosse
1
Affiliation
1
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia. sgrosse@cdc.gov.
PMID:
29765139
PMCID:
PMC6237665
DOI:
10.1038/s41436-018-0025-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Colorectal Neoplasms, Hereditary Nonpolyposis*
Cost-Benefit Analysis*
Early Detection of Cancer
Humans
Mass Screening
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States